Working Together to Accelerate Progress on NCDs Thursday, July 10, 2014 1:00 – 3:00 p.m. UN Delegates Dining Room, UN Secretariat Building 405 E. 42nd Street, Fourth Floor, New York, NY
PROGRAMME 1:00 p.m.:
Guests Arrive
1:20 p.m.:
Welcome Address by IFBA Anne Heughan, IFBA Co-Chair, External Affairs Director, Unilever
1:25 p.m.:
Welcome Address by UN Global Compact Puvan J. Selvanathan, Head, Food and Agriculture, UN Global Compact
1:30 p.m.:
Panel Introduction and Discussion The Moderator, Shannon Pettypiece, Bloomberg TV and BusinessWeek, will introduce the panel, each of whom will speak in the following order:
• • • • • •
Dr. Margaret A. Hamburg, Commissioner of Food and Drugs, U.S. Food and Drug Administration Dr. John Duperly, MD, Internal Medicine, PhD Sports Medicine, Chronic Disease Research Center, Los Andes University - Fundación Santa Fe de Bogotá, Colombia Richard Dobbs, Director, McKinsey Global Institute, Co-Leader of the McKinsey Global Institute Research on “Overcoming Obesity: A potential plan and its economics” Pilar Farjas Abadía, Secretary of State for Health and Consumer Affairs, Spanish Ministry of Health, Social Services and Equality Prof. Giorgio Calabrese, PhD, Nutrition and Dietary Studies, University of Naples Federico II Johanna Ralston, CEO, World Heart Federation, Member of the NCD Alliance Steering Group
2:25 p.m.:
Moderated Q&A Session
2:50 p.m.:
Moderator Concluding Remarks
2:55 p.m.:
Closing Remarks Mary Catherine Toker, IFBA Co-Chair, Vice President, Government and Public Affairs, General Mills
BIOGRAPHIES (In Order of Appearance)
MODERATOR Shannon Pettypiece, Healthcare Correspondent for Bloomberg News & TV
Shannon Pettypiece is a healthcare reporter with Bloomberg News. She has covered the industry for almost a decade, delving into nearly every aspect of the healthcare system, including hospitals, the FDA, the pharmaceutical industry and medical device makers. Most recently she has been reporting on the roll out of the Affordable Care Act and issues around aging. In addition to writing for the Bloomberg terminal and Bloomberg.com, her work has also appeared on Bloomberg TV, Bloomberg Radio, and in Bloomberg Businessweek. Pettypiece is a graduate of the University of Michigan where she received a bachelor's degree in political science.
PANELISTS Margaret A. Hamburg, M.D., Commissioner of Food and Drugs, U.S. Food and Drug Administration Margaret A. Hamburg, M.D. is the 21st Commissioner of the U.S. Food and Drug Administration. As the top official at the FDA, Dr. Hamburg is committed to strengthening programs and policies that enable the agency to carry out its fundamental mission — to protect and promote the public health. Only the second woman ever to serve as Commissioner, Dr. Hamburg earned her M.D. from Harvard Medical School and completed her residency at what is now New York Presbyterian Hospital-Weill Cornell Medical Center. She conducted neuroscience research at Rockefeller University in New York and at the National Institute of Mental Health, and later focused on AIDS research as Assistant Director of the National Institute of Allergy and Infectious Diseases. In 1991, after just a year in the New York City Department of Health, Dr. Hamburg was named its Commissioner. During her six-year tenure, she implemented rigorous public health initiatives that tackled the city’s most pressing crises head-on — including improved services for women and children, a needle-exchange program to combat HIV transmission, and the nation’s first public health bio-terrorism defense program. The most celebrated achievement during her leadership was her aggressive approach to the city’s tuberculosis epidemic, which led to an 86% decline in drug-resistant TB in just five years. In 1997, three years after she was elected one of the youngest-ever members of the Institute of Medicine, President Bill Clinton named Dr. Hamburg Assistant Secretary for Planning and Evaluation in the U.S. Department of Health and Human Services, where she served until the end of the Clinton Administration. She then became founding Vice President for Biological Programs at the Nuclear Threat Initiative, a foundation dedicated to reducing the threat to public safety from nuclear, chemical, and biological weapons. President Barack Obama nominated Dr. Hamburg for the post of FDA Commissioner on March 14, 2009. As the Commissioner of Food and Drugs, Dr. Hamburg has emphasized the critical role of innovation in meeting the nation’s rapidly growing public health needs. She provided leadership for the implementation of three ground-breaking measures: the Family Smoking Prevention and Tobacco Control Act, a 2009 law that gives FDA the authority to regulate the manufacture, distribution, and marketing of tobacco products; the Food Safety Modernization Act of 2011, which changed the focus of food safety measures from responding to food-borne outbreaks of illness to preventing them; and a thorough review of the system for the evaluation and approval of medical devices. Beyond these specific undertakings, Dr. Hamburg has set the agency's paramount course for fulfilling two central public health tasks. She has launched a nation-wide public-private effort to strengthen regulatory science as a means for advancing the development and evaluation of innovative, breakthrough medical products; and she is leading FDA’s transformation into a global regulatory agency capable of ensuring the safety and quality of imported food, drugs and medical devices. Commissioner Hamburg is committed to ensuring that the FDA is poised to meet the public health challenges of the 21st century.
Dr. John Duperly, MD, Internal Medicine, PhD Sports Medicine, Chronic Disease Research Center, Los Andes University - Fundación Santa Fe de Bogotá, Colombia
Dr. John Duperly brings clinical expertise from 15 years of experience in intensive care, emergency and internal medicine with a focus on chronic disease prevention, treatment and rehabilitation. He has provided evaluation and counselling for German and Colombian athletes (both recreational and Olympic) including general medical care, nutrition and training recommendations related to injury prevention and rehabilitation. Dr. Duperly is the Director of the Exercise is Medicine Latin American Regional Center. Dr. Duperly has led hundreds of lectures, seminars and clinical workshops for 20 years in English, Spanish and German at international congresses, universities and community events. He holds medical degrees from the University of Rosario in Colombia, a PhD from German Sport University and a diploma in Public Health from Heidelberg University, among several additional degrees.
Richard Dobbs, Director, McKinsey Global Institute, Co-Leader of the McKinsey Global Institute Research on “Overcoming Obesity: A potential plan and its economics”
Richard has served clients around the world in a variety of industries, ranging from high tech and financial services to petroleum, utilities, and the public sector. Clients include one of the largest Asian conglomerates, a European rail system, global oil major and the top ranked airport. He has led MGI research on obesity, urbanisation, global capital supply and demand, natural resources and the global labour market. Before joining McKinsey in 1988, Richard received a B.A. in engineering, economics, and management at Oxford University, where he obtained a first-class degree and won the Metal Box and Lubbock Prizes. He was sponsored by Shell UK during his studies and worked for Shell’s North Sea exploration and production business. He also holds an M.B.A. from Stanford Business School, where he was a Fulbright Scholar. He graduated from this course as an Arjay Miller Scholar and won the Robichek Award for Finance. He is an associate fellow of the Saïd Business School at Oxford University, where he has taught the valuation elective, an adjunct lecturer at Tsinghua University, and on the advisory board of KAIST Business School.
Pilar Farjas Abadía, Secretary of State for Health and Consumer Affairs, Spanish Ministry of Health, Social Services and Equality
Ms. Farjas has a Degree in Medicine and Surgery from the University of Saragossa specializing in Preventive Medicine and Public Health, a Degree in Sociology from the Open University as well as a Degree in Advanced Studies from the University of A Coruña. She also has a Masters in Biostatistics. She has been an occupational physician and a national health doctor in the Ministry of Health and Consumer Affairs, the person in charge of the National Plan of Hemotherapy, doctor of foreign health, Head of Service and Deputy Director General for Protection and Director General for Public Health of the Autonomous Government of Galicia. She has also served as Executive Director of the Spanish Agency of Food Safety of the Ministry of Health, Head of Cabinet of the Counsellor for Fishing Activities of the Autonomous Government of Galicia, Head of Service of Sanitary Products of the Health Department of the Autonomous Government of Galicia and councilwoman in the Town hall of A Coruña and Counsellor of Health of the Autonomous Government of Galicia. Since 2011, Ms. Farjas has served as the Under-Secretary of State for Health and Consumer Affairs in the Spanish Ministry of Health, Social Services and Equality.
Prof. Giorgio Calabrese, PhD, Nutrition and Dietary Studies, at University of Naples Federico II (Italy)
Giorgio Calabrese is Professor of Dietetics and Human Nutrition at University Federico II, Naples, Italy. He graduated in Medicine and Surgery in 1977 at the University of Catania and in 1987 he specialized in Food Science at the University of Pavia. Calabrese is an active member of the New York Academy of Science and of the American Association for the Advancement of Science of Washington. He was a member of the European Food Safety Authority (EFSA) in Brussels from 2002 to 2008. Calabrese has authored many national and international publications, and has participated in various international congresses as keynote speaker. He also writes regularly in Italian newspapers such as La Stampa, Corriere della Sera, and Repubblica. Additionally, Calabrese is a scientific consultant to the Italian Ministry of Health and Agriculture for “Expo 2015.”
Johanna Ralston, CEO, World Heart Federation, Member of the NCD Alliance Steering Group
Johanna Ralston joined the World Heart Federation, one of the founding members of NCD Alliance, as Chief Executive Officer in February 2011. The World Heart Federation is headquartered in Geneva with 200 member organizations in more than 100 countries and focuses on the global fight against heart disease and stroke, with a focus on low- and middle-income countries. Before joining the World Heart Federation, Johanna was Vice President of Global Strategies at the American Cancer Society, where she was hired in 1999 to build the Society’s global programmes, eventually developing and overseeing cancer and tobacco control projects in more than 30 countries. Johanna’s work in development and global health has also included positions at New York University and International Planned Parenthood Federation of Latin America, where she served as Program Development Advisor. Johanna studied at Harvard Business School, and studied public health at Harvard and Johns Hopkins Bloomberg School of Public Health.
